(2E)-3-(2,4-Dimethylphenyl)-N-[3-(trifluoromethyl)phenyl]prop-2-enamide

Catalog No.: 
ACUGMO251
CAS No.: 
331462-04-5
Molecular Formula: 
C18H16F3NO
Molecular Weight: 
319.33
(2E)-3-(2,4-Dimethylphenyl)-N-[3-(trifluoromethyl)phenyl]prop-2-enamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
2mg90%$56.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E)-3-(2,4-Dimethylphenyl)-N-[3-(trifluoromethyl)phenyl]prop-2-enamide
IUPAC Name(E)-3-(2,4-dimethylphenyl)-N-(3-(trifluoromethyl)phenyl)acrylamide
Molecular FormulaC18H16F3NO
Molecular Weight319.33
SMILESO=C(NC1=CC=CC(C(F)(F)F)=C1)/C=C/C2=CC=C(C)C=C2C
InChI KeyJZIFGGOACFQCIL-CMDGGOBGSA-N
Synonym(2E)-3-(2,4-dimethylphenyl)-N-[3-(trifluoromethyl)phenyl]prop-2-enamide;3-(2,4-DIMETHYLPHENYL)-N-[3-(TRIFLUOROMETHYL)PHENYL]ACRYLAMIDE;2-Propenamide, 3-(2,4-dimethylphenyl)-N-[3-(trifluoromethyl)phenyl]-
CAS No.331462-04-5

Synthetic Route by SureRoute

1. ACUGMO251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1In Stock
  4. Then
  5. ACUGMO251 route product structure diagram
    ACUGMO251331462-04-5
Inquiry

2. ACUGMO251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1In Stock
  4. Then
  5. ACUGMO251 route product structure diagram
    ACUGMO251331462-04-5
Inquiry

3. ACUGMO251 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUGMO251 route product structure diagram
    ACUGMO251331462-04-5
Inquiry

Comments (0)